期刊文献+

慢性心力衰竭患者血浆N-末端脑利钠肽与内皮素的相关性 被引量:4

Correlation of plasma NT-proBNP and ET levels in patients with chronic heart failure
下载PDF
导出
摘要 目的测定慢性心力衰竭(CHF)患者血浆N-末端脑利钠肽(NT-proBNP)和内皮素(ET)的含量,探讨二者的相关性及临床意义。方法选取58例CHF患者及20例心功能正常者,用ANALYTICS E170光电免疫发光仪对血浆NT-proBNP的含量进行测定,用放射免疫法测定血浆ET水平,并分析二者的相关性。结果①CHF患者的血浆NT-proBNP和ET含量均明显高于心功能正常组(P依次为<0.001,<0.05);②CHF患者血浆NT-proBNP与ET水平呈正相关(r=0.696,P<0.001)。结论慢性心力衰竭患者血浆NT-proBNP水平明显升高,并与ET水平呈正相关,提示NT-proBNP和ET在CHF的发生、发展中起重要作用。 【Objective】 To measure plasma N-terminal pro-brain natriuretic peptide(NT-proBNP) and endothelin(ET) concentrations in patients with chronic heart failure(CHF),and to study their correlation and clinical significance.【Methods】 A total of 78 subjects were divided into two groups:CHF patient group(58 cases),and control group(20 cases).Plasma NT-proBNP concentration was measured by ANALYTICS E170 Immunity Analyzer,plasma ET concentration was measured with radioimmunoassay,and to study their correlation was investigated.【Results】①Plasma NT-proBNP and ET concentrations increased in CHF patients compared with those of control group(P 0.001,0.05 by turns);Plasma NT-proBNP concentrations were correlated with ET in CHF patients(r =0.696,P 0.001).【Conclusion】The results suggest that the levels of plasma NT-proBNP and ET may possess important significance in development of CHF.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2010年第16期2526-2528,共3页 China Journal of Modern Medicine
关键词 慢性心力衰竭 N-末端脑利钠肽 内皮素 chronic heart failure N-terminal pro-brain natriuretic peptide(NT-proBNP) endothelin(ET)
  • 相关文献

参考文献7

二级参考文献28

  • 1陈金明,陈思聪.内皮素在冠心病方面的研究进展[J].心血管病学进展,1995,16(5):284-287. 被引量:19
  • 2Ho KK, Anderson KM, Kannel WB, et al. Survivalafter the onset of congestive heart failure in Framingham Heart Study subjects[J]. Circulation, 1993, 88(1):107- 115.
  • 3Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells[J]. Nature, 1988, 332(6163) :411 - 415.
  • 4Sutsch G, Kiowski W. Endothelin and endothelin receptor antagonist in heart failure [J]. J Cardiovasc Pharmacol,2000, 35(4 Suppl 2):S69- S73.
  • 5Turer A J, Tanzawak K. Mammalian member metallopeptidases: NEP, ECE, KELL and PEX[J]. FASEB J, 1997,11:355 - 364.
  • 6Webb DJ, Monge JC, Rabelink TJ, et al. Endothelin: new discoveries and rapid progress in the clinic [J]. Trends PharmacolSci, 1998, 19(1):5-8.
  • 7Masaki T. The endothelin family: an overview[J]. J Cardiovasc Pharmacol, 2000, 35(4 Suppl 2): S3 - S5.
  • 8Elshourbagy NA, Korman DR, Wu HL, et al. Molecular characterization and regulation of the human endothelin receptors[J]. J Biol Chem, 1993, 268(6) :3873 - 3879.
  • 9Karne S, Jayawickreme CK, Lerner MR. Cloning and characterization of an endothelin-3 specific receptor (ETc receptor) from Xenopus laevis dermal melanophores [J]. J Biol Chem, 1993, 268(25): 19126- 19133.
  • 10Ogawa Y, Nakao K, Arai H, et al. Molecular cloning of a non-isopeptide-selective human endothelin receptor [J].Biochem Biophys Res Commun, 1991, 178(1) :248 - 255.

共引文献41

同被引文献29

引证文献4

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部